Meeting
2017 Genitourinary Cancers Symposium
The impact of pretreatment MRI on genitourinary and gastrointestinal toxicity after radiation therapy in patients with localized prostate cancer.
Authors
Kyle Kilinski
University of South Florida Morsani College of Medicine, Tampa, FL
Kyle Kilinski , Arash Naghavi , Yazan Asad Abuodeh , Michelle Echevarria , Kosj Yamoah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 119)
DOI
10.1200/JCO.2017.35.6_suppl.119
Abstract #
119
Poster Bd #
B13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
First Author: Sagar A. Patel
Poster
2024 ASCO Genitourinary Cancers Symposium
Pretreatment colonoscopy impact on acute gastrointestinal (GI) toxicity following curative stereotactic body radiation therapy (SBRT) for localized prostate cancer.
First Author: Jonathan W. Lischalk
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of multiparametric magnetic resonance imaging findings with oncologic outcomes in non-palpable localized prostate cancer.
First Author: Abhishek Kumar
Poster
2020 Genitourinary Cancers Symposium
A prospective comparison of MRI-planned versus CT-planned radiotherapy for prostate cancer.
First Author: Daniel R Schmidt